| WB | 1/2000 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 1/100-1/500 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | Sarcoplasmic/endoplasmic reticulum calcium ATPase 3, SERCA3, SR Ca(2+)-ATPase 3, Calcium pump 3, ATP2A3 |
| Entrez GeneID | 489 |
| WB Predicted band size | 109.3kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human, Mouse, Rat |
| Immunogen | This ATP2A3 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 13-47 amino acids from human ATP2A3. |
+ +
以下是关于 **ATP2A3 (N-Term)** 抗体的3篇参考文献示例(注：部分内容基于文献主题和抗体应用场景的典型研究概括，具体文献可能需要根据实际数据库检索确认)：
---
1. **文献名称**: "Selective Upregulation of SERCA3 in Diabetic Platelets: Implications for Calcium Homeostasis"
**作者**: Domański et al.
**摘要**: 研究使用ATP2A3 (N-Term)抗体通过免疫荧光和Western blot分析，发现糖尿病患者的血小板中SERCA3蛋白表达显著上调，提示其在钙稳态失调中的潜在作用。
2. **文献名称**: "SERCA3 Expression Loss in Colorectal Cancer: A Marker of Tumor Progression"
**作者**: Papp et al.
**摘要**: 该研究利用ATP2A3 (N-Term)特异性抗体对结直肠癌组织进行免疫组化分析，发现SERCA3在癌变组织中表达降低，且与肿瘤分化程度和转移风险相关。
3. **文献名称**: "Characterization of SERCA3 Isoforms in Immune Cells Using Domain-Specific Antibodies"
**作者**: Martin et al.
**摘要**: 通过N端特异性ATP2A3抗体，研究者鉴定了SERCA3在T淋巴细胞和树突状细胞中的亚型分布，揭示了其亚细胞定位差异及与免疫信号通路的关联。
---
**注**：以上文献为示例性质，实际引用需以具体检索结果为准。建议通过PubMed或Google Scholar以关键词“ATP2A3 antibody N-Terminus”或“SERCA3 N-Term antibody”进一步筛选近期研究。
The ATP2A3 (N-Term) antibody is a specific immunological tool designed to detect the N-terminal region of the ATP2A3 protein, also known as sarcoplasmic/endoplasmic reticulum calcium ATPase 3 (SERCA3). This protein belongs to the SERCA family of P-type ATPases, which play a critical role in calcium homeostasis by actively transporting Ca²⁺ ions from the cytosol into the sarcoplasmic/endoplasmic reticulum. ATP2A3 is encoded by the ATP2A3 gene located on chromosome 17p13.3 and is expressed in various tissues, including platelets, endothelial cells, and specific epithelial cells, with notable roles in non-muscle cellular processes.
The N-terminal region of SERCA3 is involved in regulatory interactions and structural stability, making it a target for studying functional modifications or isoform-specific activity. Antibodies targeting this region are commonly used in techniques like Western blotting, immunohistochemistry, and immunofluorescence to investigate SERCA3 expression patterns, localization, and dysregulation in diseases. Research has linked ATP2A3 abnormalities to pathologies such as diabetes, cancer, and cardiovascular disorders, where altered calcium signaling contributes to disease progression.
This antibody’s specificity for the N-terminus helps distinguish SERCA3 from other SERCA isoforms (e.g., SERCA1. SERCA2) and detect potential post-translational modifications or splice variants. Its applications extend to both basic research and clinical studies, aiding in understanding calcium signaling mechanisms and evaluating ATP2A3 as a biomarker or therapeutic target. Proper validation, including knockout controls, is essential to confirm antibody specificity due to potential cross-reactivity with homologous regions in related proteins.
×
